Bird, guidelines on the diagnosis and management of solitary plasmacytoma of bone, extramedullary plasmacytoma and multiple solitary plasmacytomas. Imwg criteria for the diagnosis of mm inl myeloma fn. Biopsy confirmation of a monoclonal plasma cell infiltration from a single site is required for diagnosis. The common presentation of sbp is in the axial skeleton, whereas the extramedullary plasmacytoma. Solitary and extramedullary plasmacytoma department of clinical effectiveness v4 approved by the executive committee of the medical staff on 05292018 treat as plasmacytoma, see page 2 yes no 1 see physical activity, nutrition, and tobacco cessation algorithms. Progression of a solitary plasmacytoma to multiple myeloma. Multiple myeloma plasmacytoma requisition to pet centre to be completed by the referring physician. This may possibly be combined with a stem cell transplant. If it is plasma cell neoplasm consistent with a plasmacytoma or multiple myeloma, then the case would be reportable. For spb and extramedullary plasmacytoma the distinction is the presence of only one lesion.
Solitary plasmacytoma is usually considered to be the diagnosis in cases where only one plasma cell tumour is found. Guidelines on the diagnosis and management of solitary. Solitary mesenteric plasmacytoma revealed by an acute intestinal. World health organization classification of tumours of haematopoietic and lymphoid tissues, swerdlow sh, campo e, harris nl, et al. Clipping is a handy way to collect important slides you want to go back to later. Plasmacytoma is a more benign condition than multiple myeloma, although it can develop into multiple myeloma. Solitary plasmacytoma of bone and asymptomatic multiple. Radiation therapy is the commonly used treatment for both the types of solitary plasmacytoma, as solitary plasmacytomas are localized and there is only one tumor present. Original article the outcome and analysis of different. Solitary plasmacytoma of the bone is most commonly encountered in the axial skeleton skull, spine, pelvis, ribs, and sternum, accounting for 80% of cases. Radiotherapy is the common modality of treatment with, or without, adjuvant chemotherapy. However, 70 percent of people with solitary plasmacytoma eventually develop multiple myeloma. Solitary bone and extramedullary plasmacytomas are rare plasma cell proliferative disorders.
Solitary plasmacytoma of the bone can sometimes be cured with radiation therapy or surgery to destroy or remove the tumor. Solitary plasmacytoma sp is the clinical condition characterized by the localized proliferation of clonal plasma cells. Solitary plasmacytomas are uncommon plasma cell disorders, which may present as a single bone lesion pbone or extramedullary plasmacytoma pem. A populationbased registry was consulted for the diagnosis of solitary plasmacytoma between. It is important for the otolaryngologist to acquire knowledge of this disease. We report four cases of solitary plasmacytoma of the bone and an extramedullary plasmacytoma of the paranasal sinuses and soft palate. This is the least invasive treatment with the fewest side effects. Multiple solitary plasmacytoma with multifocal bone.
In patients with either solitary plasmacytoma of bone or asymptomatic mm, systemic treatment should be deferred until there is evidence of disease progression. The definition of sp has been evolving as a result of improvement in imaging technology as well as the availability of more sensitive techniques that can detect small populations of clonal plasma cells in the bone marrow. The international myeloma working group lists three types. Solitary plasmacytoma sp is characterized by a mass of neoplastic monoclonal plasma cells in either bone sbp or soft tissue without evidence of systemic disease attributing to myeloma. Solitary plasmacytoma is an infrequent form of plasma cell dyscrasia that presents as a single mass of monoclonal plasma cells, located either extramedullary or intraosseous.
Multiple myeloma may later develop in patients with solitary bone plasmacytoma 6584% at 10 years or extramedullary sites 1% at. Find out about solitary myeloma symptoms, diagnosis and treatment. Plasmacytoma can be further divided into two distinct types, namely, solitary bone plasmacytoma and solitary extramedullary plasmacytoma. Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue or within the axial skeleton. Now customize the name of a clipboard to store your clips.
Types of treatment for plasmacytoma include radiotherapy, surgery and chemotherapy. Solitary plasmacytoma of bone spb, also called osseous plasmacytoma is a localized tumor in the bone comprised of a single clone of plasma cells in the absence of other features of mm ie, anemia, hypercalcemia, renal insufficiency, or multiple lytic bone lesions. It is an infrequent form of plasma cell neoplasm and represents 5% to 10% of all plasma cell neoplasms according to the literature 15. Multiple myeloma early detection, diagnosis, and staging. Longterm outcome of patients with solitary plasmacytoma treated.
Between 1956 and 1978, nine patients with solitary plasmacytoma of bone spb and seven with extramedullary plasmacytoma emp were treated at the university of washington hospital and swedish tumor institute. Plasmacytoma refers to a tumour consisting of abnormal plasma cells that grows within the. Additional information is now available on the role of serum free light chains and pet scanning. While the treatment paradigm for solitary plasmacytoma has not changed significantly over the years, progress has been made with regard to diagnostic tools available that can risk stratify disease, offer prognostic value, and discern solitary plasmacytoma from quiescent or asymptomatic myeloma at the time of diagnosis. Section a indication choose only one plasmactyoma pet for patients with presumed solitary plasmacytoma on conventional. The side effects of plasmacytoma treatment vary based on the treatment. Adjuvant chemotherapy in the treatment of solitary bone plasmacytoma. Although radiotherapy has become the standard treatment for sp, there is no. Pdf solitary bone plasmacytomas are part of a wide range of monoclonal neoplasms that share a common progenitor in the b lymphocyte lineage. Softtissue or nonosseous extramedullary plasmacytoma emp solitary bone plasmacytoma sbp multifocal form of multiple myeloma multiple myeloma plasmablastic sarcoma t. The prognosis and treatment of solitary plasmacytomas is very. Extramedullary plasmacytoma, prognostic factors, radiotherapy. However, more than 50% of patients develop mm within 2 years after treatment. Plasmacytoma is characterized by a local accumulation of monoclonal plasma cells without criteria for multiple myeloma mm.
Solitary plasmacytoma is treated by radiotherapy or surgery. In some patients, a bone marrow aspiration can detect a low monoclonal plasma cell infiltration which indicates a high risk of early progression to an overt myeloma disease. Spb generally occurs in the pelvis, femur, humerus, and rib. Solitary plasmacytoma symptoms, diagnosis, treatments and. Primary plasmacytoma was characterized as solitary bone plasmacytoma when a single bone plasmacytoma was present 2, 3, solitary extramedullary plasmacytoma when a solitary softtissue plasmacytoma was present, or multiple solitary plasmacytoma when there was more than one localized bone or extramedullary tumor of clonal plasma cells 1. Solitary plasmacytoma is an uncommon plasma cell neoplasm that accounts for 5% to 10% of all plasma cell neoplasms. Less than 5% of patients with a plasma cell dyscrasia present with a single bone sbp or extramedullary plasmacytoma emp without evidence of systemic disease normocalcemia, absence of anemia, preservation of uninvolved immunoglobulins, or renal disease attributable to myeloma. Solitary plasmacytoma and extramedullary plasmacytoma of. In radiation therapy, there is focusing of radiation on the solitary plasmacytoma to destroy the abnormal cancerous cells. Treatment approaches and outcomes in plasmacytomas.
Solitary or extramedullary plasmacytoma memorial sloan. Plasma cell leukaemia is significantly more aggressive than myeloma and usually requires more intensive treatment. The involved free light chain must be greater than or equal to 100 mgl. Plasmacytoma treatment chemotherapy, radiation, surgery. Current guidelines stipulate that head and neck emp be treated with. It differs from multiple myeloma by the lack of hypercalcaemia, renal insufficiency, anaemia and pathological monoclonal plasmocytosis on a. Plasmocytome solitaire du mesentere revele par une occlusion intestinale. Extramedullary plasmacytoma is a plasma cell tumor that grows. The solitary plasmacytoma sp is characterized by a localized accumulation of neoplastic monoclonal plasma cells without a proof of a systemic plasma cell proliferative disorder. Localized plasmacell neoplasms are rare, and include sp of the skeletal system.
Pdf solitary extramedullary plasmacytoma of the bladder. A solitary plasmacytoma of the bone is 40% more common than an extramedullary soft tissue plasmacytoma. Thus, combining the abovementioned research results with the guidelines 9,28. Radiotherapy is the first choice of treatment in most cases. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Radiation therapy for solitary plasmacytoma and multiple. Guidelines also recommend using the term sp with minimal bone marrow. Extramedullary plasmacytoma carries a better prognosis than a solitary plasmacytoma of the bone. Solitary bone plasmacytoma local radiotherapy is the treatment of choice for solitary bone plasmacytome sbp.
Solitary extramedullary plasmacytoma of the true vocal. It is divided into two categories based on location. Diagnosis and management of solitary plasmacytoma of bone. Multiple myeloma is a type of blood cancer of the plasma cells which are found in the bone marrow. Diagnosis and management of solitary extramedullary. Radiation therapy for the solitary plasmacytoma journalagent. Solitary plasmacytomas represent approximately 5% of all patients with myeloma. Multiple myelomaplasmacytoma requisition to pet centre. Since the previous guideline several new articles on prognostic factors, treatment and outcome in patients with solitary plasmacytoma of bone have been published. Radiation therapy for treating solitary plasmacytoma. A plasmacytoma is a discrete, solitary mass of neoplastic monoclonal plasma cells in either bone or soft tissue extramedullary. They then need additional treatment, such as chemotherapy. The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma and have considerable impact on the management of the disease. Multiple myeloma early detection, diagnosis, and staging 1.
Solitary bone plasmacytoma is a lesion of the bone whereas solitary extramedullary plasmacytoma is a lesion of soft tissue. The current treatment regimen is local radiotherapy. A plasmacytoma is a discrete, solitary mass of neoplastic monoclonal plasma. Solitary bone plasmacytoma and extramedullary plasmacytoma. A type of cancer from plasma cells where the plasma cells multiply uncontrollably. Diagnosis, treatment, and response assessment in solitary. Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue. Solitary plasmacytoma sp is a plasma cell disorder characterized by localized accumulation of neoplastic monoclonal plasma cells in bone, or in soft tissues with no skeletal component, without any evidence of systemic involvement as demonstrated by the lack of clonal plasma cells in the bone marrow and absence of features of endorgan damage. The prognosis and treatment of solitary plasmacytomas is very different to multiple myeloma. If the diagnosis is plasmacytoma and there is no additional information to indicate if its a plasmacytoma of the bone or an extramedullary plasmacytoma, default to plasmacytoma of the bone and assign histology, 973.
It differs from multiple myeloma by the lack of hypercalcaemia, renal insufficiency, anaemia and pathological monoclonal plasmocytosis on a random bone. It is potentially curable when it presents as a solitary plasmacytoma of bone or as an extramedullary plasmacytoma. Solitary plasmacytoma of the bone spb is a malignant proliferation of plasma cells that occurs within the axial skeleton and is characterized by destruction of the bone. It is critical to determine if this is an isolated plasmacytoma or if the patients already has multiple myeloma see testing. Learn about myeloma plasmacytoma solitary myeloma and how it differs from multiple myeloma. International myeloma working group imwg criteria for the diagnosis of multiple myeloma. Multiple solitary plasmacytoma msp is a rare plasma cell dyscrasia, characterised by multiple lesions of neoplastic monoclonal plasma cells. Currently, radiation therapy remains the primary choice of treatment for spb, as plasmacytoma is a radio. Solitary bone and extramedullary plasmacytoma hematology. Malignant bone tumours of the spine are extremely rare solitary plasmacytoma. A solitary plasmacytoma is a single cancer site that may involve the bone osseous or other tissues extraosseous or extramedullary. If the cancer is located in only one part of the body it is called a solitary plasmacytoma and if there are multiple sites it is called a multiple myeloma. International myeloma working group updated criteria for. The prognosis for plasmacytoma depends on whether the lesions are solitary or a sign of multiple myeloma.
159 109 24 57 390 1489 359 918 401 1254 1190 1273 1055 356 1340 790 1166 1377 285 1202 1075 200 521 1068 787 1307 992 775 1153 397 733 651 813 301 1207 92 430